|
|
||||||||
J Thorac Cardiovasc Surg 2005;129:261-267
© 2005 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Division of Thoracic and Foregut Surgery
b Department of Dental Public Health
c University of Pittsburgh Medical Center, Pittsburgh, Pa, the Division of Thoracic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, Calif
d Division of Thoracic Surgery, City of Hope Medical Center, Duarte, Calif
e Division of Thoracic Surgery, Allegheny General Hospital, Pittsburgh, Pa
Read at the Eighty-fourth Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, April 25-28, 2004.
Received for publication April 22, 2004; revisions received August 26, 2004; accepted for publication September 3, 2004. * Address for reprints: Hiran C. Fernando, FRCS, Associate Professor, Department of Cardiothoracic Surgery, Boston Medical Center, 88 East Newton St, Robinson B402, Boston, MA 02118 (E-mail: hiran.fernando{at}bmc.org).
OBJECTIVE: Computed tomographic screening is detecting ever smaller peripheral nonsmall cell lung cancers. These smaller cancers are amenable to sublobar resection, but sublobar resection is not currently the treatment of choice. This study compared sublobar resection with lobar resection for stage IA nonsmall cell lung cancers to assess whether sublobar resection is appropriate treatment for certain lesions. The use of adjuvant brachytherapy was also evaluated.
METHODS: A retrospective multicenter study of 291 patients with T1 N0 disease was done. Outcomes after sublobar resection (n = 124) were compared with those after lobar resection (n = 167). Brachytherapy was used in conjunction with 60 (48%) sublobar resection operations. Analysis based on tumor diameter was performed.
RESULTS: There were 137 cancers smaller than 2 cm and 154 cancers ranging from 2 to 3 cm. Patients undergoing sublobar resection were older (68.4 vs 66.1 years, P = .018) with poorer pulmonary function (forced expiratory volume in 1 second of 53.1% vs 78.2%, P = .001). Mean follow-up was 34.5 months. Brachytherapy decreased local recurrence rate significantly among patients undergoing sublobar resection, from 11 (17.2%) to 2 (3.3%). For tumors smaller than 2 cm, there was no difference in survival between sublobar resection and lobar resection groups. For the larger tumors (2-3 cm), median survival was significantly better in the lobar resection group, at 70 versus 44.7 months (P = .003).
CONCLUSION: Intraoperative brachytherapy may reduce the local recurrence that is usually reported with sublobar resection. Our experience supports the further investigation of the use of sublobar resection with brachytherapy for peripheral stage IA nonsmall cell lung cancers smaller than 2 cm.
This article has been cited by other articles:
![]() |
J. A. Cesaretti, A. Pennathur, B. S. Rosenstein, S. J. Swanson, and H. C. Fernando Stereotactic Radiosurgery for Thoracic Malignancies Ann. Thorac. Surg., February 1, 2008; 85(2): S785 - S791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Schuchert, B. L. Pettiford, S. Keeley, T. A. D'Amato, A. Kilic, J. Close, A. Pennathur, R. Santos, H. C. Fernando, J. R. Landreneau, et al. Anatomic Segmentectomy in the Treatment of Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 926 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Scott, J. Howington, S. Feigenberg, B. Movsas, and K. Pisters Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 234S - 242S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. El-Sherif, H. C. Fernando, R. Santos, B. Pettiford, J. D. Luketich, J. M. Close, and R. J. Landreneau Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer Ann. Surg. Oncol., August 1, 2007; 14(8): 2400 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Birdas, R. P.M. Koehler, A. Colonias, M. Trombetta, R. H. Maley Jr, R. J. Landreneau, and R. J. Keenan Sublobar Resection With Brachytherapy Versus Lobectomy for Stage Ib Nonsmall Cell Lung Cancer Ann. Thorac. Surg., February 1, 2006; 81(2): 434 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Inoue, H. Shiono, M. Monami, and M. Okumura Malignant margin in wedge resection for peripheral lung cancer and adjuvant radiotherapy J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1479 - 1480. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |